RU97115054A - MEANS FOR TREATMENT OF ONCOLOGIC PATIENTS - Google Patents

MEANS FOR TREATMENT OF ONCOLOGIC PATIENTS

Info

Publication number
RU97115054A
RU97115054A RU97115054/14A RU97115054A RU97115054A RU 97115054 A RU97115054 A RU 97115054A RU 97115054/14 A RU97115054/14 A RU 97115054/14A RU 97115054 A RU97115054 A RU 97115054A RU 97115054 A RU97115054 A RU 97115054A
Authority
RU
Russia
Prior art keywords
treatment
oncologic patients
patients
oncologic
dimethyltryptomine
Prior art date
Application number
RU97115054/14A
Other languages
Russian (ru)
Other versions
RU2108786C1 (en
Inventor
К.С. Евланенкова
Original Assignee
К.С. Евланенкова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.С. Евланенкова filed Critical К.С. Евланенкова
Priority to RU97115054/14A priority Critical patent/RU2108786C1/en
Priority claimed from RU97115054/14A external-priority patent/RU2108786C1/en
Priority to AU80417/98A priority patent/AU8041798A/en
Priority to PCT/RU1998/000112 priority patent/WO1999013873A1/en
Application granted granted Critical
Publication of RU2108786C1 publication Critical patent/RU2108786C1/en
Publication of RU97115054A publication Critical patent/RU97115054A/en

Links

Claims (1)

Применение L-триптофана или 5-гидрокси-NN-диметилтриптомина в качестве средств для лечения онкологических больных.The use of L-tryptophan or 5-hydroxy-NN-dimethyltryptomine as agents for the treatment of cancer patients.
RU97115054/14A 1997-09-15 1997-09-15 Agent for treatment of oncological patients RU2108786C1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU97115054/14A RU2108786C1 (en) 1997-09-15 1997-09-15 Agent for treatment of oncological patients
AU80417/98A AU8041798A (en) 1997-09-15 1998-04-17 Agent for treating patients suffering from tumours
PCT/RU1998/000112 WO1999013873A1 (en) 1997-09-15 1998-04-17 Agent for treating patients suffering from tumours

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU96120368/14 1996-09-27
RU96120369/14 1996-09-27
RU97115054/14A RU2108786C1 (en) 1997-09-15 1997-09-15 Agent for treatment of oncological patients

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
RU96120369 Division
RU96120368 Division

Publications (2)

Publication Number Publication Date
RU2108786C1 RU2108786C1 (en) 1998-04-20
RU97115054A true RU97115054A (en) 1999-02-20

Family

ID=20196976

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97115054/14A RU2108786C1 (en) 1997-09-15 1997-09-15 Agent for treatment of oncological patients

Country Status (3)

Country Link
AU (1) AU8041798A (en)
RU (1) RU2108786C1 (en)
WO (1) WO1999013873A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389203B8 (en) 2001-02-27 2010-03-10 The Governement of the United States of America, represented by The Secretary Department of Health and Human services Analogs of thalidomide as angiogenesis inhibitors
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
BRPI0414497A (en) 2003-09-17 2006-11-14 Us Gov Health & Human Serv thalidomide analogs
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU666794A1 (en) * 1976-07-01 1984-03-23 Предприятие П/Я В-8469 Process for preparing dl-triptophan
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them

Similar Documents

Publication Publication Date Title
ATE231724T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF PSYCHOSIS
BR9603841A (en) Apparatus for the treatment of hyperthermic tumors
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
ID16878A (en) INDOL DERIVES THAT ARE USEFUL FOR TREATMENT
NO20005884L (en) Combination therapy for the treatment of bipolar disorders
ATE239509T1 (en) CONJUGATES FOR THE TREATMENT OF PROSTATE CANCER
DE69731747D1 (en) PEPTID DERIVATIVES
DK0752870T3 (en) Use of Mycobacterium for the treatment of tumors
NO20001869D0 (en) Procedures for the treatment of Alzheimer's disease
NO20003229L (en) Combination of benzocycloheptapyridine compounds and antineoplastic agents for the treatment of proliferative diseases
NO991459D0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
ATE261434T1 (en) TRIPTOLIDE DERIVATIVES SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE69735417D1 (en) 2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
RU97115054A (en) MEANS FOR TREATMENT OF ONCOLOGIC PATIENTS
NO984432L (en) Procedure for the treatment of migraine pain
HUP0101947A3 (en) Combination for the treatment of tumors
NO913117L (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
NO984189D0 (en) Procedure for the treatment of bipolar disorder
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20002481D0 (en) Combination therapy for the treatment of AIDS
RU97115190A (en) ANTISEPTIC WATER TREATMENT
RU95118900A (en) Antitumor agent
RU97111440A (en) DRUG FOR TREATING FROZEN